T. J. de Vries

Heterogeneous expression of immunotherapy candidate proteins gp100, MART-1, and tyrosinase in human melanoma cell lines and in human melanocytic lesions.

T. J. de Vries, A Fourkour, Th. Wobbes et al. · PubMed · 1997 · 191 citations

Medicine, Immunology, Oncology +17

Heterogeneous expression of the SSX cancer/testis antigens in human melanoma lesions and cell lines.

Nuno R. dos Santos, Ruurd Torensma, T. J. de Vries et al. · PubMed · 2000 · 151 citations

Life Sciences, Molecular Biology, Oncology +17

Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression.

T. J. de Vries, Paul H.A. Quax, M. Denijn et al. · PubMed · 1994 · 149 citations

Medicine, Cancer Biology, Oncology +17

E-cadherin expression in human melanoma

Erik H.J. Danen, T. J. de Vries, R. Morandini et al. · Melanoma Research · 1996 · 114 citations

Medicine, Oncology, Pathology +16

Expression of gp100, MART-1, tyrosinase, and S100 in paraffin-embedded primary melanomas and locoregional, lymph node, and visceral metastases: implications for diagnosis and immunotherapy. A study conducted by the EORTC Melanoma Cooperative Group

T. J. de Vries, Miriam Smeets, Ruurd de Graaf et al. · The Journal of Pathology · 2001 · 108 citations

Medicine, Oncology, Pathology +17